A federal choose in Chicago lately shot down a category motion bid accusing the leaders of a pharmaceutical firm of deceptive traders by concealing two advertising packages that provided healthcare suppliers free companies in alternate for prescribing an arthritis remedy.
Trending
- ‘Throw the parcel at the door’
- US puts £31bn tech ‘prosperity deal’ with Britain on ice | Trade policy
- ADWEEK 2026 Creative 100 Now Open for Nominations
- Ofcom investigates BT and Three for failing to connect 999 calls
- Ludlow food bank demand triples
- Strada Receives Strategic Investment From OWC to Accelerate Cloud-Free Collaboration
- Roomba maker iRobot bought by Chinese supplier after filing for bankruptcy | Manufacturing sector
- Charisse Hughes to Depart Kellanova Following Mars Deal
‘Untenably Broad:’ Federal Judge Dismisses Class Action Kickback Claims Against Chicago Pharmaceutical Company
